Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1: A case report.
Saved in:
| Title: | Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1: A case report. |
|---|---|
| Authors: | Inoue, Takako1 (AUTHOR) takako.inoue@oici.jp, Kunimasa, Kei1 (AUTHOR), Tamiya, Motohiro1 (AUTHOR), Kawamura, Takahisa1 (AUTHOR), Minami, Toshiyuki2,3 (AUTHOR), Nishino, Kazumi1 (AUTHOR) |
| Source: | Thoracic Cancer. Apr2024, Vol. 15 Issue 11, p929-933. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17597706 |
|---|---|
| DOI: | 10.1111/1759-7714.15254 |
